Montelukast Sodium Tablet, Coated
Product Images NDC 68084-875

6 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 68084-875). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp87501

Ahp87501
Montelukast Sodium 10 mg coated tablet, brown square with rounded edges. One side is embossed with the letter 'R' and the other side shows the imprint '725'. This oral prescription drug is labeled by American Health Packaging.*
FDA Label Image

Figure 1: Change In Height (cm) From Randomization Visit By Scheduled Week (treatment Group Mean ± Standard Error* Of The Mean) (Figure 1)

Figure 1: Change In Height (cm) From Randomization Visit By Scheduled Week (treatment Group Mean ± Standard Error* Of The Mean) (Figure 1)
A line graph depicting change in height (cm) over weeks on treatment for three groups: Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and Placebo. The x-axis shows treatment duration in weeks from -19 to 56, and the y-axis shows change in height ranging from -3 to 7 cm. All groups start near zero and show an increasing trend in height over time, with Montelukast and Beclomethasone generally showing similar growth above placebo.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of montelukast sodium depicted as a molecular diagram showing its atomic connections, including chlorine, sulfur, and sodium components.*
FDA Label Image

Figure 2: Fev1 Mean Percent Change From Baseline (u.s. Trial: Montelukast Sodium N=406; Placebo N=270) (anova Model) (Figure1.jpg)

Figure 2: Fev1 Mean Percent Change From Baseline (u.s. Trial: Montelukast Sodium N=406; Placebo N=270) (anova Model) (Figure1.jpg)
A line graph showing the mean percent change from baseline over weeks in treatment comparing Montelukast Sodium with placebo. The x-axis represents weeks in treatment from 0 to 15, including a washout period, and the y-axis shows mean percent change from baseline ranging from 0 to 15. Montelukast Sodium data points increase rapidly and remain higher than placebo throughout the treatment period, with error bars shown for both groups.*
FDA Label Image

10 mg Montelukast Sodium Tablets Carton (10 mg Montelukast Sodium Tablets Carton)

10 mg Montelukast Sodium Tablets Carton (10 mg Montelukast Sodium Tablets Carton)
Montelukast Sodium 10 mg coated tablets label from American Health Packaging. The label indicates the medication is for adults 15 years and older, with a package containing 100 tablets (10 x 10 count). Includes NDC 68084-875-01 and dispensing information along with storage instructions and a QR code for the Medication Guide and Prescribing Information.*
FDA Label Image

10 mg Montelukast Sodium Tablet Blister (10 mg Montelukast Sodium Tablet Blister)

10 mg Montelukast Sodium Tablet Blister (10 mg Montelukast Sodium Tablet Blister)
Montelukast Sodium Tablet, USP 10 mg coated tablets label for oral use from American Health Packaging. Intended for adults 15 years of age and older. The label shows lot number 1234567 and expiration date 12/21. The NDC number 68084-875 is visible. The label is repeated multiple times on the sheet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.